A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction
Condition: Breast Reduction Interventions: Drug: Bupivacaine Hydrochloride; Drug: Liposomal Bupivacaine Sponsor: Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials